| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/17/1997 | US5639884 Antitumor agents |
| 06/17/1997 | US5639796 Injectable medical composition and method of use |
| 06/17/1997 | US5639792 No synthetase inhibitors as medicinal products intended to reduce alcohol consumption or to prevent excessive alcohol consumption |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639782 Antiinflammatory agent; antiallergens |
| 06/17/1997 | US5639781 Alcohol or aldehyde derivatives and their use |
| 06/17/1997 | US5639779 Treatment of different types of headaches |
| 06/17/1997 | US5639778 Indoletetralins having dopaminergic activity |
| 06/17/1997 | US5639768 Leukototriene receptor antagonist; antinflammatory agents |
| 06/17/1997 | US5639752 Serotonin agonist |
| 06/17/1997 | US5639749 Inhibitors of glycinamide ribonucleotide formyl transferase; antitumor agents |
| 06/17/1997 | US5639747 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/17/1997 | US5639746 Inhibitors of metalloprotease |
| 06/17/1997 | US5639745 Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639458 Class I MHC modulation of surface receptor activity |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/12/1997 | WO1997020856A1 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES |
| 06/12/1997 | WO1997020843A1 Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 06/12/1997 | WO1997020833A1 Benzofuran carboxamides and sulphonamides |
| 06/12/1997 | WO1997020824A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/12/1997 | WO1997020580A1 Drug therapy |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020561A1 Composition for treating pain |
| 06/12/1997 | WO1997012963A3 A paf-acetylhydrolase and use in therapy |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239203A1 Drug therapy |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2238815A1 Composition for treating pain |
| 06/12/1997 | CA2238306A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778284A2 New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778266A1 5-Amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of beta-amyloid protein production |
| 06/11/1997 | EP0778026A1 Remedy for endotoxinemia and multiple organ failure induced thereby |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0777748A1 Peptide librairies as a source of syngenes |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777680A1 Urokinase receptor ligands |
| 06/11/1997 | EP0777671A1 Spiro-azabicyclic compounds useful in therapy |
| 06/11/1997 | EP0777666A1 Novel substituted piperidines useful for the treatment of allergic diseases |
| 06/11/1997 | EP0777660A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 06/11/1997 | EP0777659A1 Morpholine derivatives and their use as therapeutic agents |
| 06/11/1997 | EP0777653A1 Dihygropyridine derivatives as bradykinin antagonists |
| 06/11/1997 | EP0777650A1 Biphenylamide derivatives as 5ht 1d? antagonists |
| 06/11/1997 | EP0777649A1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists |
| 06/11/1997 | EP0777646A1 Metalloproteinase inhibitors |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777491A1 Use of tasteless, hydrolysed collagen and agent containing the same |
| 06/11/1997 | EP0777489A1 Low molecular yeast active substance extract and process for preparing the same |
| 06/11/1997 | EP0777487A1 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction |
| 06/11/1997 | EP0777484A1 Intravenous alendronate formulations |
| 06/11/1997 | EP0777478A1 Inhibitors of rotamase enzyme activity |
| 06/11/1997 | EP0777475A1 Inhibitors of farnesyl-protein transferase |
| 06/11/1997 | EP0777472A2 Methods for identifying and treating resistant tumors |
| 06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 06/11/1997 | EP0711141B1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
| 06/11/1997 | EP0703913B1 Imidazoles as lipoxygenase inhibitors |
| 06/11/1997 | EP0700395B1 Indole derivatives as steroid 5-alpha-reductase inhibitors |
| 06/11/1997 | EP0557305B1 (2-thienyl) alkylamine derivatives having neuroprotective properties |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | CN1151760A Serum paraoxonase |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/11/1997 | CN1151735A Benzocycloalkylazolethione derivatives |
| 06/11/1997 | CN1151732A Tri-substituted phenyl derivates useful as PDE IV inhibitors |
| 06/11/1997 | CN1151729A Aryl and heteroaryl alkoxynaphtalene derivatives |
| 06/11/1997 | CN1151697A Anti-hiv triple combination |
| 06/11/1997 | CN1151405A Propiophenone derivative and processes for preparing the same |
| 06/10/1997 | US5637712 Process of preparing isoquinoline compounds |
| 06/10/1997 | US5637711 Chemical intermediate; 1-epoxidemethyl substituted piperazine ring |
| 06/10/1997 | US5637698 Fused multiple ring lactams |
| 06/10/1997 | US5637697 1,5-benzodiazepine derivatives and their use in medicine |
| 06/10/1997 | US5637684 Phosphoramidate and phosphorothioamidate oligomeric compounds |
| 06/10/1997 | US5637624 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| 06/10/1997 | US5637620 Micro formoterol particles |
| 06/10/1997 | US5637611 Vasoconstructive agents; migraine |
| 06/10/1997 | US5637610 Composition containing dioxabicyclo [3.3.0] octane derivative |
| 06/10/1997 | US5637609 2-phenylpyrrole derivatives as dopamine D3 receptor antagonists |
| 06/10/1997 | US5637606 Hair grower based on allantoin or derivatives thereof |
| 06/10/1997 | US5637605 α-fluoro-α-1-(1,2,4-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors |
| 06/10/1997 | US5637604 Treatment and control of ocular development |
| 06/10/1997 | US5637602 Nervous system disorders; gastrointestinal disorders |
| 06/10/1997 | US5637600 Phenylpyrrole derivatives and their use as dopamine D3 antagonists |
| 06/10/1997 | US5637598 Methods of inhibiting bone loss |
| 06/10/1997 | US5637596 Reacting aminomethylindole derivative with a carbonyl containing cyclizing agent; 5-ht3 receptor atagonist; useful for treating anxiety, psychosis, gut motility disorder, emesis, migraine and drug addiction |
| 06/10/1997 | US5637591 Antimicrobial and anticollagenase activity of phenazine-5, 10-dioxide and derivatives |
| 06/10/1997 | US5637586 Angiotensin inhibitor; hypotensive agent |